PRISCILLA RAMSAY: Open Payments
NPI 1942253810 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 9 payments from 7 companies in 2025. Trend: 2023 $115 · 2024 $56 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| PhotoniCare Inc | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, Kerendia, REXULTI, MOUNJARO, AIRSUPRA, OtoSight Middle Ear Scope, AZMIRO.
Industry payments across SC — which companies pay providers there.
